185 related articles for article (PubMed ID: 31974428)
1. Transcriptional regulation of the IL-13Rα2 gene in human lung fibroblasts.
Penke LR; Ouchi H; Speth JM; Lugogo N; Huang YJ; Huang SK; Peters-Golden M
Sci Rep; 2020 Jan; 10(1):1083. PubMed ID: 31974428
[TBL] [Abstract][Full Text] [Related]
2. CXCR3 Requirement for the Interleukin-13-Mediated Up-Regulation of Interleukin-13Rα2 in Pulmonary Fibroblasts.
Barnes JC; Lumsden RV; Worrell J; Counihan IP; O'Beirne SL; Belperio JA; Fabre A; Donnelly SC; Boylan D; Kane R; Keane MP
Am J Respir Cell Mol Biol; 2015 Aug; 53(2):217-25. PubMed ID: 25514189
[TBL] [Abstract][Full Text] [Related]
3. CXCR3A promotes the secretion of the antifibrotic decoy receptor sIL-13Rα2 by pulmonary fibroblasts.
Worrell JC; Walsh SM; Fabre A; Kane R; Hinz B; Keane MP
Am J Physiol Cell Physiol; 2020 Dec; 319(6):C1059-C1069. PubMed ID: 33026833
[TBL] [Abstract][Full Text] [Related]
4. Cigarette smoke extracts induce overexpression of the proto-oncogenic gene interleukin-13 receptor α2 through activation of the PKA-CREB signaling pathway to trigger malignant transformation of lung vascular endothelial cells and angiogenesis.
Meng M; Liao H; Zhang B; Pan Y; Kong Y; Liu W; Yang P; Huo Z; Cao Z; Zhou Q
Cell Signal; 2017 Feb; 31():15-25. PubMed ID: 27986643
[TBL] [Abstract][Full Text] [Related]
5. Endogenously expressed IL-13Rα2 attenuates IL-13-mediated responses but does not activate signaling in human lung fibroblasts.
Chandriani S; DePianto DJ; N'Diaye EN; Abbas AR; Jackman J; Bevers J; Ramirez-Carrozzi V; Pappu R; Kauder SE; Toy K; Ha C; Modrusan Z; Wu LC; Collard HR; Wolters PJ; Egen JG; Arron JR
J Immunol; 2014 Jul; 193(1):111-9. PubMed ID: 24879793
[TBL] [Abstract][Full Text] [Related]
6. Implications of IL-13Rα2 in atopic skin inflammation.
Furue M; Ulzii D; Nakahara T; Tsuji G; Furue K; Hashimoto-Hachiya A; Kido-Nakahara M
Allergol Int; 2020 Jul; 69(3):412-416. PubMed ID: 32037147
[TBL] [Abstract][Full Text] [Related]
7. Role of hypoxia-inducible factor 1, α subunit and cAMP-response element binding protein 1 in synergistic release of interleukin 8 by prostaglandin E2 and nickel in lung fibroblasts.
Brant KA; Fabisiak JP
Am J Respir Cell Mol Biol; 2013 Jul; 49(1):105-13. PubMed ID: 23526216
[TBL] [Abstract][Full Text] [Related]
8. IL-13 signaling through IL-13 receptor α2 mediates airway epithelial wound repair.
Yang SJ; Allahverdian S; Saunders ADR; Liu E; Dorscheid DR
FASEB J; 2019 Mar; 33(3):3746-3757. PubMed ID: 30481486
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of prostaglandin E
Mukherjee S; Sengupta Bandyopadhyay S
Biochem J; 2018 Jan; 475(2):477-494. PubMed ID: 29269396
[TBL] [Abstract][Full Text] [Related]
10. IL-13 induces YY1 through the AKT pathway in lung fibroblasts.
Guo J; Yao H; Lin X; Xu H; Dean D; Zhu Z; Liu G; Sime P
PLoS One; 2015; 10(3):e0119039. PubMed ID: 25775215
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2.
Ikari J; Michalski JM; Iwasawa S; Gunji Y; Nogel S; Park JH; Nelson AJ; Farid M; Wang X; Schulte N; Basma H; Toews ML; Feghali-Bostwick C; Tenor H; Liu X; Rennard SI
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):571-81. PubMed ID: 23656623
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tumor necrosis factor alpha-induced prostaglandin E2 production by the antiinflammatory cytokines interleukin-4, interleukin-10, and interleukin-13 in osteoarthritic synovial fibroblasts: distinct targeting in the signaling pathways.
Alaaeddine N; Di Battista JA; Pelletier JP; Kiansa K; Cloutier JM; Martel-Pelletier J
Arthritis Rheum; 1999 Apr; 42(4):710-8. PubMed ID: 10211885
[TBL] [Abstract][Full Text] [Related]
13. TNF-α/IL-17 synergy inhibits IL-13 bioactivity via IL-13Rα2 induction.
Badalyan V; Thompson R; Addo K; Borthwick LA; Fisher AJ; Ort T; Myers TG; Wynn TA; Ramalingam TR
J Allergy Clin Immunol; 2014 Oct; 134(4):975-8.e5. PubMed ID: 24954262
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid induces interleukin-13 (IL-13) receptor alpha2 expression and inhibits IL-13 signaling in primary human bronchial epithelial cells.
Zhao Y; He D; Zhao J; Wang L; Leff AR; Spannhake EW; Georas S; Natarajan V
J Biol Chem; 2007 Apr; 282(14):10172-9. PubMed ID: 17287216
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2-induced IL-23p19 subunit is regulated by cAMP-responsive element-binding protein and C/AATT enhancer-binding protein β in bone marrow-derived dendritic cells.
Kocieda VP; Adhikary S; Emig F; Yen JH; Toscano MG; Ganea D
J Biol Chem; 2012 Oct; 287(44):36922-35. PubMed ID: 22977257
[TBL] [Abstract][Full Text] [Related]
16. Alcohol primes the airway for increased interleukin-13 signaling.
Mitchell PO; Jensen JS; Ritzenthaler JD; Roman J; Pelaez A; Guidot DM
Alcohol Clin Exp Res; 2009 Mar; 33(3):505-13. PubMed ID: 19120067
[TBL] [Abstract][Full Text] [Related]
17.
He CH; Lee CG; Ma B; Kamle S; Choi AMK; Elias JA
Am J Respir Cell Mol Biol; 2020 Sep; 63(3):386-395. PubMed ID: 32402213
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of IL-13 and IL-13Rα2 Expression by IL-32θ in Human Monocytic Cells Requires PKCδ and STAT3 Association.
Pham TH; Bak Y; Oh JW; Hong J; Lee S; Hong JT; Yoon DY
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010051
[TBL] [Abstract][Full Text] [Related]
19. Identification of serum interleukin-13 and interleukin-13 receptor subunit expressions: Rheumatoid arthritis-associated interstitial lung disease.
Hussein MS; El-Barbary AM; Nada DW; Gaber RA; Elkolaly RM; Aboelhawa MA
Int J Rheum Dis; 2021 Apr; 24(4):591-598. PubMed ID: 33638296
[TBL] [Abstract][Full Text] [Related]
20. Effect of IL-13 receptor alpha2 levels on the biological activity of IL-13 variant R110Q.
Andrews AL; Bucchieri F; Arima K; Izuhara K; Holgate ST; Davies DE; Holloway JW
J Allergy Clin Immunol; 2007 Jul; 120(1):91-7. PubMed ID: 17560640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
